Overview

Inhaled Nitric Oxide and Neuroprotection in Premature Infants

Status:
Active, not recruiting
Trial end date:
2021-06-07
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether inhaled nitric oxide improves the neurological outcome for premature infants.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Chicago
Treatments:
Nitric Oxide